Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Dingo Medica AS
AS
Active
Org 919480866
Stenkjørerbakken 26, 1684
Vesterøy
Medical specialists activities
·
NACE 8622
Est. 2017 · 8 years old
1 employees
Monitor
Share
Norway
/
Companies
/
Medical specialists activities
/
Dingo Medica AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
5M
4M
2M
1M
0M
2020: 4M
4M
2020
2021: 4M (0% vs 2020)
4M
0%
2021
2022: 4M (0% vs 2021)
4M
0%
2022
2023: 4M (0% vs 2022)
4M
0%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
EBITDA
NOK millions
2M
2M
1M
1M
0M
2020: 1M
1M
2020
2021: 2M (+100% vs 2020)
2M
+100%
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
4 307
4 297
4 171
4 271
4 234
Staff expenses
−1 903
−1 366
−1 175
−1 056
−908
EBITDA
424
1 009
1 219
1 552
1 491
Depreciation & amort.
−36
−64
−58
−46
−39
EBIT
388
946
1 160
1 506
1 452
Net financials
1
0
0
0
−1
Profit before tax
389
946
1 160
1 506
1 451
Tax
88
212
258
335
320
Net profit
301
734
902
1 171
1 131
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
1 612
2 228
3 371
3 495
2 439
Equity
517
840
841
1 906
1 822
Long-term debt
0
0
0
0
0
Short-term debt
1 095
1 388
2 530
1 589
617
Total debt
1 095
1 388
2 530
1 589
617
Financial ratios
5-year trend
EBITDA margin
9,8 %
This company
15,8 %
Market median
This company
Market median
38% below market
2020
2024
Equity ratio
32,1 %
This company
38,2 %
Market median
This company
Market median
16% below market
2020
2024
Return on equity
58,2 %
This company
18,4 %
Market median
This company
Market median
216% above market
2020
2024
Net profit margin
7,0 %
This company
8,1 %
Market median
This company
Market median
14% below market
2020
2024
Asset turnover
2,67×
This company
1,12×
Market median
This company
Market median
138% above market
2020
2024
Debt / equity
2,12×
This company
0,62×
Market median
This company
Market median
242% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Dingo Medica AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
